Eye care biopharma commercializing XDEMVY and building a clinical pipeline
Tarsus is a NASDAQ-listed biopharma in Irvine whose hiring is director-heavy and split across field sales, healthcare and research, consistent with a commercial launch running alongside pipeline work. The stack pairs a deep Salesforce marketing suite (Data Cloud, Marketing Cloud Personalization, Einstein) with Veeva Vault, Phoenix WinNonlin and Databricks, pointing to a data-driven commercial engine plus in-house PK and clinical analytics.
Notable leadership hires: Regional Director, Sales Director, Clinical Sciences Director
Tarsus Pharmaceuticals is a public biopharmaceutical company founded in 2017 and headquartered in Irvine, California, with 201–500 employees. Its initial focus is eye care, with XDEMVY as the commercial product it is launching and growing. The company runs clinical trials, medical science liaison programs and advisory boards, and works with contract manufacturers on formulation and technology transfer. Hiring spans the United States and Peru, covering sales, research, healthcare, manufacturing and operations.
Tarsus uses Veeva Vault, Salesforce (Marketing Cloud, Data Cloud, Einstein Analytics), Databricks, Snowflake, Azure, Tableau, Power BI, NetSuite, FloQast, Adaptive Planning, SAS, JMP and Phoenix WinNonlin.
Job posts point to the XDEMVY launch and growth, a tablet formulation strategy, pharmacokinetic strategy across the portfolio, clinical trials, MSL education and scaling its contract manufacturing network.
Yes. Hiring is accelerating with a director-heavy mix, including Regional Director and Sales Director roles, alongside research, healthcare and clinical sciences positions in the United States and Peru.
Other companies in the same industry, closest in size
Tarsus Pharmaceuticals, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.